Table 7.
Lipid indexes in the liver samples.
| Group | TC | TG | HDL-C | LDL-C | AST | ALT |
|---|---|---|---|---|---|---|
| (mg/dL) | (mg/dL) | (mg/dL) | (mg/dL) | (U/L) | (U/L) | |
| A | 66.63 ± 4.093 | 147.22 ± 6.180 | 57.79 ± 10.96 | 10.74 ± 2.186 | 3286 ± 817.8 | 1048 ± 344.9 |
| B | 100.2 ± 19.22*** | 200.0 ± 32.56*** | 76.05 ± 25.82 | 28.36 ± 12.57** | 2539 ± 308.4 | 1302 ± 519.2 |
| C | 105.8 ± 15.01*** | 197.8 ± 18.56*** | 79.92 ± 17.93** | 28.79 ± 7.821*** | 2673 ± 428.4 | 1470 ± 424.5* |
| D | 87.71 ± 17.19** | 180.8 ± 15.94*** | 66.38 ± 17.49 | 24.49 ± 6.547*** | 2900 ± 541.4 | 1394 ± 309.6 |
| E | 57.18 ± 6.754∗∗, ### | 153.6 ± 27.34# | 84.69 ± 19.50** | 24.86 ± 4.385*** | 1830 ± 288.3∗∗∗, ## | 1040 ± 490.1 |
| F | 66.29 ± 28.08#,†† | 162.1 ± 39.88† | 88.55 ± 35.98* | 38.39 ± 18.53*** | 1907 ± 582.8∗∗, #,†† | 1268 ± 737.5 |
| G | 89.48 ± 18.75** | 205.8 ± 29.90*** | 139.6 ± 24.43∗∗∗, ##,††† | 48.98 ± 12.02∗∗∗, #,†† | 3661 ± 700.6## | 1380 ± 693.9 |
| H | 69.82 ± 24.30# | 165.0 ± 32.11 | 128.8 ± 49.55∗∗, # | 41.89 ± 16.49∗∗∗,† | 3579 ± 705.4##,††† | 1607 ± 592.9* |
| I | 43.67 ± 2.936∗∗∗, ### | 150.8 ± 18.82## | 83.79 ± 19.69** | 9.990 ± 3.548## | 3538 ± 304.4### | 1971 ± 622.0∗∗, # |
| J | 44.66 ± 5.379∗∗∗, ### | 195.8 ± 25.96*** | 73.20 ± 46.50 | 15.79 ± 9.505 | 4244 ± 545.0∗, ### | 953.5 ± 167.7 |
All these biochemical indexes were assayed by assay kits as described in the text.
The * indicates a significant difference compared with control group, *P < 0.05, **P < 0.01, ***P < 0.001.
The # indicates a significant difference compared with model group, # P < 0.05, ## P < 0.01, ### P < 0.001.
The † indicates a significant difference compared with PMR group (same dosage level, F compared with C, G compared to D, H compared to E), † P < 0.05, †† P < 0.01, ††† P < 0.001.